| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b65baeb523304db96746f9d12113181 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61C8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 |
| filingDate |
2005-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dddbeb2822eaf6fca70f9ee51383f4bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a71052aa496790af17a839db5297283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_679772dc03ce8aae753f2441a8793bb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb114352cdf5662ca362bdf9c78f557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af57de33cf6ceb2491a2f497ede697c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df6afbd71801e3cce9dd1d4ff7b83066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c16af09f9f19d547260300af7bb4ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d4076a936e9358a88507165199cf82d |
| publicationDate |
2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005216093-A1 |
| titleOfInvention |
Implant made with titanium or titanium alloy and surface treating method thereof |
| abstract |
To provide a surface modified implant made with titanium or a titanium alloy in which a bone bonding can be made easily and certainly as compared with conventional ones and treating method thereof, the surface of the implant made with titanium or the titanium alloy is treated with polyphosphoric acid and basic fibroblast growth factor (bFGF), and the method comprises treating with a polyphosphoric acid solution having a concentration of 0.05 to 70% by weight and with a basic fibroblast growth factor (bFGF) solution having a concentration of 1 to 500 ng/ml, or treating with a mixed solution having the concentration of the polyphosphoric acid of 0.05 to 70% by weight and the concentration of the basic fibroblast growth factor (bFGF) of 1 to 500 ng/ml. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014223867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009164011-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9493335-B2 |
| priorityDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |